g-rich

hVEGF-IN-1 inhibits human VEGF-A translation and has antitumor activity.

Guanosine 5'-triphosphate trisodium salt (5'-GTP trisodium salt) activates signal-transducing G proteins involved in cellular processes such as proliferation, differentiation, and activation of intracellular kinase cascades. It regulates proliferation and apoptosis through the hydrolysis by small GTPases Ras and Rho, and plays a role in vesicle docking, fusion, and formation via Rab. Additionally, GTP serves as an energy-rich precursor for the biosynthesis of DNA and RNA.

Guanosine triphosphate tritris (GTP tritris) serves as a crucial enhancer in myocyte differentiation, playing an essential role in regulating miRNA-muscle regulatory factors. It promotes the release of exosomes rich in guanine and guanine-derived molecules, and is considered an activation precursor for RNA synthesis. In mitochondrial functionality, GTP is involved in the entry of proteins into the matrix, which is vital for various regulatory pathways. It initiates peptide synthesis by facilitating the binding of formylmethionine-tRNA to the ribosome, and aids in polypeptide chain elongation. Additionally, GTP acts as a carrier for phosphates and pyrophosphates, channeling chemical energy into specific biosynthetic pathways. It activates signal transduction G proteins, regulates cellular processes such as proliferation and differentiation, and its hydrolysis by small GTPases (including Ras and Rho) is indispensable for both proliferation and apoptosis. Furthermore, the small GTPase Rab assists in vesicle docking, fusion, and formation. Beyond signal transduction, GTP is also an energy-rich precursor in the biosynthesis of DNA and RNA enzymes.

Elsamitrucin is a heterocyclic antineoplastic antibiotic isolated from the bacterium Actinomycete strain J907-21. Elsamitrucin intercalates into DNA at guanine-cytosine (G-C)-rich sequences and inhibits topoisomerase I and II, resulting in single-strand breaks and inhibition of DNA replication. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).

BNC-101 is a humanized monoclonal antibody targeting Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5/GPR49). LGR5 is a key component of the Wnt signaling pathway and a critical marker of cancer stem cells (CSCs) in various malignancies, particularly colorectal and pancreatic cancers. BNC-101 binds specifically to the extracellular domain of LGR5 with high affinity, inhibiting the abnormal activation of the Wnt/beta-catenin signaling pathway by blocking the interaction between LGR5 and its ligands, R-spondins. This antibody is designed to reduce tumor tumorigenicity, recurrence, and metastatic potential by targeting and eliminating LGR5-positive cancer stem cells.

LB Nutrient Agar is a nutrient-rich medium initially developed for the growth and maintenance of Escherichia coli strains. It is currently the most widely used medium for bacterial growth. Each liter of LB Nutrient Agar contains: 10.0 g of tryptone, 5.0 g of yeast extract, 10.0 g of sodium chloride, and 15.0 g of agar.